EGFR and lung adenocarcinoma: A representative example of this bimodal distribution was shown by the top ranking comparison, i.e., lung tumors driven by mutations of either the EGFR or the KRAS oncogenes, which characterize two distinct genomic subtypes of lung adenocarcinoma [25] (Fig. 1e).